Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Microglia protect brain via inhibition

Oct. 9, 2020

Study indicates potential of bosutinib to treat neurodegenerative conditions

Oct. 8, 2020

Phase II study of neflamapimod for dementia with Lewy bodies meets primary endpoint

Oct. 7, 2020

Angiotensin inhibitors for AD prevention

Oct. 7, 2020

Santhera ends development of idebenone following phase III futility analysis

Oct. 6, 2020

NervGen provides updates regarding development of NVG-291

Oct. 6, 2020

Neural stem cells open to alternate fates

Oct. 5, 2020

E-Scape Bio discloses LRRK2 inhibitors

Oct. 5, 2020

FDA lifts clinical hold on Solid's phase I/II study of SGT-001 in DMD

Oct. 2, 2020

Alterity Therapeutics identifies compounds that modulate biological metals

Oct. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...